Search Results - "laharie, david"

Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial by Cosnes, Jacques, Bourrier, Anne, Laharie, David, Nahon, Stéphane, Bouhnik, Yoram, Carbonnel, Franck, Allez, Matthieu, Dupas, Jean–Louis, Reimund, Jean–Marie, Savoye, Guillaume, Jouet, Pauline, Moreau, Jacques, Mary, Jean–Yves, Colombel, Jean–Frédéric

“…Background & Aims Immunomodulator therapy is effective for patients with Crohn’s disease (CD) but has not been shown to affect disease progression, presumably…”
Get full text

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial by Laharie, David, Prof, Bourreille, Arnaud, MD, Branche, Julien, MD, Allez, Matthieu, Prof, Bouhnik, Yoram, Prof, Filippi, Jerome, MD, Zerbib, Frank, Prof, Savoye, Guillaume, Prof, Nachury, Maria, MD, Moreau, Jacques, MD, Delchier, Jean-Charles, Prof, Cosnes, Jacques, Prof, Ricart, Elena, MD, Dewit, Olivier, Prof, Lopez-Sanroman, Antonio, MD, Dupas, Jean-Louis, Prof, Carbonnel, Franck, Prof, Bommelaer, Gilles, Prof, Coffin, Benoit, Prof, Roblin, Xavier, MD, Van Assche, Gert, Prof, Esteve, Maria, MD, Färkkilä, Martti, Prof, Gisbert, Javier P, MD, Marteau, Philippe, Prof, Nahon, Stephane, MD, de Vos, Martine, Prof, Franchimont, Denis, Prof, Mary, Jean-Yves, PhD, Colombel, Jean-Frederic, Prof, Lémann, Marc, Prof

“…Summary Background Ciclosporin and infliximab are potential rescue treatments to avoid colectomy in patients with acute severe ulcerative colitis refractory to…”
Get full text

Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study by Rayer, Cassandra, Nachury, Maria, Bourreille, Arnaud, Roblin, Xavier, Peyrin-Biroulet, Laurent, Viennot, Stephanie, Flamant, Mathurin, Laharie, David, Caron, Bénédicte, Dewitte, Marie, Siproudhis, Laurent, Fumery, Mathurin, Bouguen, Guillaume

“…No study has performed a face-to-face comparison of biologics after the failure of the first anti-TNF agent in patients with Crohn's disease (CD). The aim of…”
Get full text

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer by Lavelle, Aonghus, Nancey, Stéphane, Reimund, Jean-Marie, Laharie, David, Marteau, Philippe, Treton, Xavier, Allez, Matthieu, Roblin, Xavier, Malamut, Georgia, Oeuvray, Cyriane, Rolhion, Nathalie, Dray, Xavier, Rainteau, Dominique, Lamaziere, Antonin, Gauliard, Emilie, Kirchgesner, Julien, Beaugerie, Laurent, Seksik, Philippe, Peyrin-Biroulet, Laurent, Sokol, Harry

“…Due to the potential role of the gut microbiota and bile acids in the pathogenesis of both inflammatory bowel disease (IBD) and sporadic colorectal cancer, we…”
Get full text

Compliance with Gluten Free Diet Is Associated with Better Quality of Life in Celiac Disease by Enaud, Raphaël, Tetard, Candice, Dupuis, Raphaël, Laharie, David, Lamireau, Thierry, Zerbib, Frank, Rivière, Pauline, Shili-Mismoudi, Sarah, Poullenot, Florian

“…The quality of life (QOL) of patients with celiac disease (CD) can be altered by both symptoms of the disease and by the restrictions of the gluten-free diet…”
Get full text

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial by LÉmann, Marc, Mary, Jean–Yves, Duclos, Bernard, Veyrac, Michel, Dupas, Jean–Louis, Delchier, Jean Charles, Laharie, David, Moreau, Jacques, Cadiot, Guillaume, Picon, Laurence, Bourreille, Arnaud, Sobahni, Iradj, Colombel, Jean–Frederic

“…Background & Aims: The aim of this study was to evaluate the usefulness of short-term infliximab combined with azathioprine (AZA) or 6-mercaptopurine (6-MP) in…”
Get full text

Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study by Rayer, Cassandra, Nachury, Maria, Bourreille, Arnaud, Roblin, Xavier, Peyrin-Biroulet, Laurent, Viennot, Stephanie, Flamant, Mathurin, Laharie, David, Caron, Bénédicte, Dewitte, Marie, Siproudhis, Laurent, Fumery, Mathurin, Bouguen, Guillaume

Get full text

A single dedicated vaccination visit improves vaccination coverage of patients with inflammatory bowel disease by Le Cosquer, Guillaume, Grangeon, Lionel, Rivière, Pauline, Berger, Arthur, Zerbib, Frank, Laharie, David, Poullenot, Florian

“…Introduction: Patients treated with biologics for inflammatory bowel disease (IBD) have an increased risk of severe infections. Real-life vaccination coverage…”
Get full text

Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn’s Disease by Marteau, Philippe, Laharie, David, Colombel, Jean-Frédéric, Martin, Laurence, Coevoet, Hugues, Allez, Matthieu, Cadiot, Guillaume, Bourreille, Arnaud, Carbonnel, Franck, Bouhnik, Yoram, Coffin, Benoit, Duclos, Bernard, Dupas, Jean Louis, Moreau, Jacques, Louis, Edouard, Mary, Jean-Yves

“…Background: After resection surgery for Crohn’s disease, recurrence of endoscopic lesions at the site of the anastomosis or in the neoterminal ileum is graded…”
Get full text

Predictors of Perianal Fistula Relapse in Crohn’s Disease by Malian, Audrey, Rivière, Pauline, Bouchard, Dominique, Pigot, François, Eléouet-Kaplan, Marianne, Favreau-Weltzer, Charlotte, Poullenot, Florian, Laharie, David

“…We investigated fistula relapse in patients in remission after treatment of perianal Crohn’s disease fistulae. We show that relapse rates are not different…”
Get full text

The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics by Lelong, Margaux, Josien, Régis, Coste-Burel, Marianne, Rimbert, Marie, Bressollette-Bodin, Céline, Nancey, Stéphane, Bouguen, Guillaume, Allez, Matthieu, Serrero, Mélanie, Caillo, Ludovic, Rouillon, Cléa, Blanc, Pierre, Laharie, David, Olivier, Raphaël, Peyrin-Biroulet, Laurent, Dib, Nina, De Maissin, Astrid, Montuclard, Céline, Trang-Poisson, Caroline, Vavasseur, Fabienne, Gallot, Géraldine, Berthome, Mathilde, Braudeau, Cécile, Chevreuil, Justine, Bourreille, Arnaud, Le Berre, Catherine

“…Background Patients with inflammatory bowel disease (IBD) may have a modified immune response to SARS-CoV-2. The objectives were to evaluate the prevalence of…”
Get full text

Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID by Caron, Bénédicte, Seksik, Philippe, Buisson, Anthony, Wils, Pauline, Savoye, Guillaume, Stefanescu, Carmen, Laharie, David, Guillo, Lucas, Abitbol, Vered, Bonnet, Joelle, Altwegg, Romain, Vuitton, Lucine, Moussata, Driffa, Bourreille, Arnaud, Biron, Amélie, Gilletta, Cyrielle, Fumery, Mathurin, Nahon, Stephane, Nancey, Stephane, Camara, Houda, Peyrin-Biroulet, Laurent

“…Several adalimumab preparations are now available for patients with inflammatory bowel disease (IBD). Comparative satisfaction and tolerability are unknown…”
Get full text

Letter: Should ulcerative colitis be monitored more or less invasively? by Laharie, David

“…LINKED CONTENT This article is linked to Lenfant et al papers. To view these articles, visit https://doi.org/10.1111/apt.17753 and…”
Get full text

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy by Poullenot, Florian, Seksik, Philippe, Beaugerie, Laurent, Amiot, Aurélien, Nachury, Maria, Abitbol, Vered, Stefanescu, Carmen, Reenaers, Catherine, Fumery, Mathurin, Pelletier, Anne-Laure, Nancey, Stephane, Peyrin-Biroulet, Laurent, Bourreille, Arnaud, Hébuterne, Xavier, Brixi, Hedia, Savoye, Guillaume, Lourenço, Nelson, Altwegg, Romain, Buisson, Anthony, Cazelles-Boudier, Christine, Racine, Antoine, Vergniol, Julien, Laharie, David

“…Patients with inflammatory bowel disease (IBD) and history of malignancy within the last 5 years are usually contraindicated for receiving anti-tumor necrosis…”
Get full text

Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors by Darrigade, Anne-Sophie, Milpied, Brigitte, Truchetet, Marie-Elise, Schaeverbeke, Thierry, Laharie, David, Zerbib, Frank, Beylot-Barry, Marie, Jouary, Thomas, Taïeb, Alain, Ezzedine, Khaled, Seneschal, Julien

“…Psoriasiform eruptions are a classical adverse skin reaction of tumour necrosis factor (TNF)-α inhibitors. The aim of this study was to identify the…”
Get full text

Reply by Laharie, David

Get full text

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study by Amiot, Aurelien, Bourrier, Anne, Gornet, Jean-Marc, Dewit, Olivier, Nancey, Stephane, Altwegg, Romain, Abitbol, Vered, Laharie, David, Reenaers, Catherine, Gagnière, Charlotte, Buisson, Anthony, Nachury, Maria, Viennot, Stephanie, Vuitton, Lucine, Stefanescu, Carmen, Marteau, Philippe, Bouguen, Guillaume, Seksik, Philippe

“…Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is…”
Get full text

Editorial: is enteral nutrition back in acute severe ulcerative colitis? by Laharie, David

“…LINKED CONTENT This article is linked to Sahu et al papers. To view these articles, visit https://doi.org/10.1111/apt.16249 and…”
Get full text

Towards therapeutic choices in ulcerative colitis by Laharie, David

“…Within the past few decades ulcerative colitis has become a worldwide condition, with the highest prevalence reported in developed countries and increasing…”
Get full text

Editorial: selecting therapy for ulcerative colitis—think a step ahead by Laharie, David, Riviere, Pauline

“…LINKED CONTENT This article is linked to Straatmijer et al papers. To view these articles, visit https://doi.org/10.1111/apt.17248…”
Get full text